2022
DOI: 10.3389/fneur.2022.866274
|View full text |Cite
|
Sign up to set email alerts
|

Non-Invasive Prediction of Survival Time of Midline Glioma Patients Using Machine Learning on Multiparametric MRI Radiomics Features

Abstract: ObjectivesTo explore the feasibility of predicting overall survival (OS) of patients with midline glioma using multi-parameter magnetic resonance imaging (MRI) features.MethodsData of 84 patients with midline gliomas were retrospectively collected, including 40 patients with OS > 12 months (28 cases were adults, 14 cases were H3 K27M-mutation) and 44 patients with OS < 12 months (29 cases were adults, 31 cases were H3 K27M-mutation). Features were extracted from the largest slice of tumors, which… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…A recent systematic review of the current status and quality of radiomics for glioma differential diagnosis in 2022 showed that the radiomic quality score (RQS) of 42 studies was only 24.21%, which meant that current radiomic studies for glioma differential diagnosis still lack the quality required to allow its introduction into clinical practice [ 26 , 27 ]. We identified several research trends based on radiomics and gliomas (not only DMG), including construction using multiparametric magnetic resonance radiomics (several MRI sequences combined with genotype status and clinical features), [ 25 , 28 , 29 ]; PET-extracted radiomics [ 30 , 31 , 32 , 33 ]; radiomics-based machine learning [ 34 , 35 , 36 ]; predictive models of recurrence [ 37 , 38 ]; survival and classification in gliomas [ 39 , 40 , 41 ]; and differential diagnosis [ 42 , 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…A recent systematic review of the current status and quality of radiomics for glioma differential diagnosis in 2022 showed that the radiomic quality score (RQS) of 42 studies was only 24.21%, which meant that current radiomic studies for glioma differential diagnosis still lack the quality required to allow its introduction into clinical practice [ 26 , 27 ]. We identified several research trends based on radiomics and gliomas (not only DMG), including construction using multiparametric magnetic resonance radiomics (several MRI sequences combined with genotype status and clinical features), [ 25 , 28 , 29 ]; PET-extracted radiomics [ 30 , 31 , 32 , 33 ]; radiomics-based machine learning [ 34 , 35 , 36 ]; predictive models of recurrence [ 37 , 38 ]; survival and classification in gliomas [ 39 , 40 , 41 ]; and differential diagnosis [ 42 , 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…Using the multiparametric MRI features of HGGs, Deng and co-workers developed four radiomic models for the survival prognosis of midline glioma patients [106] (Figure 10F) (Table 2). All four models taken individually were adequate for sensitivity and specificity.…”
Section: Major Findingmentioning
confidence: 99%
“…Predicting the survival of patients with glioma has substantial clinical value and poses challenges for radiologists in routine clinical practice. Radiomics models based on multimodal images perform better than monomodal images [42]. Advanced MRI images (diffusion, perfusion, arterial spin labeling and MR spectroscopy) have also been used for prognostication [43][44][45][46].…”
Section: Monitoring Response To Treatmentmentioning
confidence: 99%